Anja Harmeier

Chief Executive Officer at

ReWind Therapeutics NV

Health Technology

Consumer Services

Finance

Profile

Anja Harmeier is Chief Executive Officer at ReWind Therapeutics NV since 2021.
Also holds the position of Director at uniQure France SAS. Serves as Head-Roche Venture Fund at Roche Ventures since 2017.
Former roles include Director at Zikani Therapeutics, Inc., Minoryx Therapeutics SL, Entrada Therapeutics, Inc., and Vico Therapeutics BV.
Partner at Pureos Partners AG from 2020 to 2022.
Education includes an MBA from Instituto de Empresa SL in 2015 and a doctorate from Freie Universität Berlin in 2008.

Anja Harmeier active positions

Companies	Position	Start
Roche Ventures Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing.	Private Equity Investor	01/03/2017
Corlieve Therapeutics SAS Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases	Director/Board Member	-
ReWind Therapeutics NV ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies	Chief Executive Officer	22/09/2021

All active positions of Anja Harmeier

Former positions of Anja Harmeier

Companies	Position	End
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Private Equity Investor	31/08/2022
Vico Therapeutics BV Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies	Director/Board Member	-
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products	Director/Board Member	-
ENTRADA THERAPEUTICS, INC.	Director/Board Member	-
Zikani Therapeutics, Inc. Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens	Director/Board Member	-

See the detail of Anja Harmeier's experience

Training of Anja Harmeier

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anja Harmeier's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Zikani Therapeutics, Inc. Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens	Retail Trade
Roche Ventures Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing.	Finance
Instituto de Empresa SL Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Freie Universität Berlin Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products	Health Technology
ReWind Therapeutics NV ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops novel re-myelinating therapies	Health Technology
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Finance
Entrada Therapeutics, Inc. Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases	Health Technology
Vico Therapeutics BV Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies	Health Technology
Corlieve Therapeutics SAS Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases	Health Technology